Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SHIRISH MADHAV GADGEEL

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1033156534
CMS profile
273900
Location
DETROIT, MI

General Payments · PY2018–2024

$409,427.39

  • Reported across 376 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$52,593.38

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $8,779.31 4
Amgen Inc. $8,136.02 5
AstraZeneca UK Limited $6,288.20 6
Daiichi Sankyo Inc. $5,540.55 8
Janssen Biotech, Inc. $5,308.83 8
Takeda Pharmaceuticals U.S.A., Inc. $4,941.19 5
ABBVIE INC. $4,194.00 4
Gilead Sciences, Inc. $2,870.00 1
Acerta Pharma LLC $2,736.77 7
Janssen Scientific Affairs, LLC $2,025.00 1
F. Hoffmann-La Roche AG $1,710.00 2
Genentech USA, Inc. $46.49 1
Regeneron Healthcare Solutions, Inc. $17.02 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $80,597.50 80
PY2019 $89,929.97 91
PY2020 $66,981.90 49
PY2021 $44,559.66 29
PY2022 $27,957.34 33
PY2023 $46,807.64 41
PY2024 $52,593.38 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $600.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 1103134571 CMS
ABBVIE INC. $675.00 08/02/2024 Consulting Fee Undisputed 01/23/2026 1103134573 CMS
ABBVIE INC. $19.00 09/07/2024 Food and Beverage Undisputed 01/23/2026 1103763626 CMS
ABBVIE INC. $2,900.00 10/30/2024 Consulting Fee Undisputed 01/23/2026 1103134575 CMS
Amgen Inc. $2,744.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 1117557957 CMS
Amgen Inc. $48.97 05/15/2024 Food and Beverage Undisputed 01/23/2026 1115640814 CMS
Amgen Inc. $141.19 06/02/2024 Food and Beverage Undisputed 01/23/2026 1117557953 CMS
Amgen Inc. $5,145.00 08/07/2024 Consulting Fee Undisputed 01/23/2026 1117557951 CMS
Amgen Inc. $56.86 10/23/2024 Food and Beverage Undisputed 01/23/2026 1117557955 CMS
AstraZeneca Pharmaceuticals LP $52.39 02/21/2024 Food and Beverage Undisputed 01/23/2026 1110533846 CMS
AstraZeneca Pharmaceuticals LP $22.17 02/21/2024 Food and Beverage Undisputed 01/23/2026 1110542191 CMS
AstraZeneca Pharmaceuticals LP $49.25 02/21/2024 Food and Beverage Undisputed 01/23/2026 1110549756 CMS
AstraZeneca Pharmaceuticals LP $80.18 02/21/2024 Food and Beverage Undisputed 01/23/2026 1110552422 CMS
AstraZeneca Pharmaceuticals LP $45.26 02/21/2024 Food and Beverage Undisputed 01/23/2026 1110553492 CMS
AstraZeneca Pharmaceuticals LP $27.52 03/30/2024 Food and Beverage Undisputed 01/23/2026 1110547390 CMS
AstraZeneca Pharmaceuticals LP $2,460.00 10/17/2024 Consulting Fee Undisputed 01/23/2026 1110547130 CMS
AstraZeneca UK Limited $60.00 04/17/2024 Travel and Lodging Undisputed 01/23/2026 1110539467 CMS
AstraZeneca UK Limited $2,740.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 1110541801 CMS
AstraZeneca UK Limited $120.76 04/17/2024 Travel and Lodging Undisputed 01/23/2026 1110549594 CMS
AstraZeneca UK Limited $23.69 04/17/2024 Food and Beverage Undisputed 01/23/2026 1110551088 CMS
AstraZeneca UK Limited $1,738.75 09/27/2024 Consulting Fee Undisputed 01/23/2026 1110543509 CMS
AstraZeneca UK Limited $1,605.00 11/25/2024 Consulting Fee Undisputed 01/23/2026 1110531597 CMS
Daiichi Sankyo Inc. $104.83 05/31/2024 Food and Beverage Undisputed 01/23/2026 1089423659 CMS
Daiichi Sankyo Inc. $2,500.00 07/17/2024 Consulting Fee Undisputed 01/23/2026 1089423649 CMS
Daiichi Sankyo Inc. $65.00 09/07/2024 Food and Beverage Undisputed 01/23/2026 1089423645 CMS
Daiichi Sankyo Inc. $40.00 09/07/2024 Food and Beverage Undisputed 01/23/2026 1089423647 CMS
Daiichi Sankyo Inc. $336.98 10/09/2024 Travel and Lodging Undisputed 01/23/2026 1089423651 CMS
Daiichi Sankyo Inc. $149.99 10/09/2024 Travel and Lodging Undisputed 01/23/2026 1089423653 CMS
Daiichi Sankyo Inc. $1,875.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1089423657 CMS
Daiichi Sankyo Inc. $468.75 10/16/2024 Consulting Fee Undisputed 01/23/2026 1089423655 CMS
F. Hoffmann-La Roche AG $570.00 01/01/2024 Consulting Fee Undisputed 01/23/2026 1133112887 CMS
F. Hoffmann-La Roche AG $1,140.00 10/01/2024 Consulting Fee Undisputed 01/23/2026 1133112891 CMS
Genentech USA, Inc. $46.49 06/02/2024 Food and Beverage Undisputed 01/23/2026 1133112883 CMS
Gilead Sciences, Inc. $2,870.00 07/22/2024 Consulting Fee Undisputed 01/23/2026 1133600099 CMS
Janssen Biotech, Inc. $826.35 02/27/2024 Travel and Lodging Undisputed 01/23/2026 1078743148 CMS
Janssen Biotech, Inc. $24.19 03/06/2024 Travel and Lodging Undisputed 01/23/2026 1078741830 CMS
Janssen Biotech, Inc. $294.70 03/06/2024 Travel and Lodging Undisputed 01/23/2026 1078742051 CMS
Janssen Biotech, Inc. $142.62 03/06/2024 Travel and Lodging Undisputed 01/23/2026 1078742908 CMS
Janssen Biotech, Inc. $31.08 03/07/2024 Food and Beverage Undisputed 01/23/2026 1078742386 CMS
Janssen Biotech, Inc. $150.59 03/07/2024 Travel and Lodging Undisputed 01/23/2026 1078742900 CMS
Janssen Biotech, Inc. $126.80 03/08/2024 Travel and Lodging Undisputed 01/23/2026 1078742577 CMS
Janssen Biotech, Inc. $3,712.50 03/22/2024 Consulting Fee Undisputed 01/23/2026 1078742468 CMS
Janssen Scientific Affairs, LLC $2,025.00 08/02/2024 Consulting Fee Undisputed 01/23/2026 1078852346 CMS
PFIZER INC. $133.68 02/22/2024 Food and Beverage Undisputed 01/23/2026 1131587587 CMS
PFIZER INC. $1,825.00 03/12/2024 Consulting Fee Undisputed 01/23/2026 1131202372 CMS
PFIZER INC. $1,075.63 06/03/2024 Travel and Lodging Undisputed 01/23/2026 1132037274 CMS
PFIZER INC. $5,745.00 06/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131915736 CMS
Regeneron Healthcare Solutions, Inc. $17.02 08/15/2024 Education Undisputed 01/23/2026 1114051814 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,025.00 04/04/2024 Consulting Fee Undisputed 01/23/2026 1144957722 CMS
Takeda Pharmaceuticals U.S.A., Inc. $529.69 04/04/2024 Travel and Lodging Undisputed 01/23/2026 1144957724 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,025.00 04/04/2024 Consulting Fee Undisputed 01/23/2026 1144957726 CMS
Takeda Pharmaceuticals U.S.A., Inc. $118.28 05/06/2024 Food and Beverage Undisputed 01/23/2026 1144957728 CMS
Takeda Pharmaceuticals U.S.A., Inc. $243.22 05/09/2024 Food and Beverage Undisputed 01/23/2026 1144957730 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.